| Title | Research Area | Implementing Organisations | Funding Organisations | Start Year | Status |
|---|---|---|---|---|---|
| Pharmacological and Molecular Approaches to Investigate Selected Drug in Model of Ischemia-Reperfusion Injury in Streptozotocin Induced Diabetic Rats | Pharmaceutical Sciences | All India Institute of Medical Sciences (AIIMS) | Bristol-Myers Squibb (BMS) Company, USA | 2018 | Completed |
| NIHR Global Health Research Group on Psychosis Outcomes: Protocol based assessment and management of First Episode Psychosis (AIIMS Centre) | Medical Sciences | All India Institute of Medical Sciences (AIIMS) | National Institute for Health Research (NIHR), UK | 2018 | Completed |
| Flipping to empower adolescents for sexual and reproductive health | Medical Sciences | All India Institute of Medical Sciences (AIIMS) | Grand Challenges, Canada | 2018 | Completed |
| Bone mineral density and chronic alcoholism and changes following disulfiram deaddiction therapy | Medical Sciences | All India Institute of Medical Sciences (AIIMS) | Department of Biotechnology (DBT) | 2017 | Completed |
| Exploring the role of intracellularly formed sphingosine 1-phosphate in mediating anti-atherogenic effects of adiponectin on endothelial cells | Life Sciences & Biotechnology | All India Institute of Medical Sciences (AIIMS) | The Wellcome Trust/DBT India Alliance | 2017 | Completed |
| Exome sequencing based detection of novel and causal mutation(s) associated with juvenile onset open angle glaucoma (JOAG) | Medical Sciences | All India Institute of Medical Sciences (AIIMS) | Defence Research and Development Organization (DRDO), Govt. of India | 2017 | Completed |
| Study of pain attributes to design a pain measurement device for the cancer and injured patients | Medical Sciences | All India Institute of Medical Sciences (AIIMS) | Defence Research and Development Organization (DRDO), Govt. of India | 2017 | Completed |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis | Medical Sciences | All India Institute of Medical Sciences (AIIMS) | Gilead Sciences, Inc., USA | 2017 | Completed |
| A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohns Disease | Medical Sciences | All India Institute of Medical Sciences (AIIMS) | Gilead Sciences, Inc., USA | 2017 | Completed |
| A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis | Medical Sciences | All India Institute of Medical Sciences (AIIMS) | Gilead Sciences, Inc., USA | 2017 | Completed |
Accessibility Controls